Safety and Efficacy of RM-001 (Autologous HBG1/2 Promoter-modified CD34+Hematopoietic Stem and Progenitor Cells) in Patients with Transfusion-Dependent Thalassemia
BLOOD(2023)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined